[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pain Relievers Market Size, Status and Forecast 2020-2026

August 2020 | 129 pages | ID: G3E300261F65EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Pain Relievers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pain Relievers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
  • Pfizer
  • GSK
  • Grunenthal
  • Bayer
  • Sanofi
  • Eli Lilly
  • AstraZeneca
  • Endo
  • Merck
  • Depomed
  • Yunnan Baiyao
  • Teva
  • J&J
  • Allergan
  • Purdue
  • Reckitt Benckiser Group Plc
  • Novartis AG
  • Topical BioMedics
  • AdvaCare Pharma
  • Sun Pharmaceutical
Market segment by Type, the product can be split into
  • Nonsteroidal Anti-inflammatory Drugs
  • Central Analgesics
Market segment by Application, split into
  • Headache
  • Toothache
  • Arthralgia
  • Menstrual Pain
  • Other
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pain Relievers Revenue
1.4 Market by Type
  1.4.1 Global Pain Relievers Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Nonsteroidal Anti-inflammatory Drugs
  1.4.3 Central Analgesics
1.5 Market by Application
  1.5.1 Global Pain Relievers Market Share by Application: 2020 VS 2026
  1.5.2 Headache
  1.5.3 Toothache
  1.5.4 Arthralgia
  1.5.5 Menstrual Pain
  1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Pain Relievers Market Perspective (2015-2026)
2.2 Global Pain Relievers Growth Trends by Regions
  2.2.1 Pain Relievers Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pain Relievers Historic Market Share by Regions (2015-2020)
  2.2.3 Pain Relievers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pain Relievers Market Growth Strategy
  2.3.6 Primary Interviews with Key Pain Relievers Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pain Relievers Players by Market Size
  3.1.1 Global Top Pain Relievers Players by Revenue (2015-2020)
  3.1.2 Global Pain Relievers Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pain Relievers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pain Relievers Market Concentration Ratio
  3.2.1 Global Pain Relievers Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pain Relievers Revenue in 2019
3.3 Pain Relievers Key Players Head office and Area Served
3.4 Key Players Pain Relievers Product Solution and Service
3.5 Date of Enter into Pain Relievers Market
3.6 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE (2015-2026)

4.1 Global Pain Relievers Historic Market Size by Type (2015-2020)
4.2 Global Pain Relievers Forecasted Market Size by Type (2021-2026)

5 MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Pain Relievers Market Size by Application (2015-2020)
5.2 Global Pain Relievers Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pain Relievers Market Size (2015-2020)
6.2 Pain Relievers Key Players in North America (2019-2020)
6.3 North America Pain Relievers Market Size by Type (2015-2020)
6.4 North America Pain Relievers Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pain Relievers Market Size (2015-2020)
7.2 Pain Relievers Key Players in Europe (2019-2020)
7.3 Europe Pain Relievers Market Size by Type (2015-2020)
7.4 Europe Pain Relievers Market Size by Application (2015-2020)

8 CHINA

8.1 China Pain Relievers Market Size (2015-2020)
8.2 Pain Relievers Key Players in China (2019-2020)
8.3 China Pain Relievers Market Size by Type (2015-2020)
8.4 China Pain Relievers Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pain Relievers Market Size (2015-2020)
9.2 Pain Relievers Key Players in Japan (2019-2020)
9.3 Japan Pain Relievers Market Size by Type (2015-2020)
9.4 Japan Pain Relievers Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pain Relievers Market Size (2015-2020)
10.2 Pain Relievers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pain Relievers Market Size by Type (2015-2020)
10.4 Southeast Asia Pain Relievers Market Size by Application (2015-2020)

11 INDIA

11.1 India Pain Relievers Market Size (2015-2020)
11.2 Pain Relievers Key Players in India (2019-2020)
11.3 India Pain Relievers Market Size by Type (2015-2020)
11.4 India Pain Relievers Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pain Relievers Market Size (2015-2020)
12.2 Pain Relievers Key Players in Central & South America (2019-2020)
12.3 Central & South America Pain Relievers Market Size by Type (2015-2020)
12.4 Central & South America Pain Relievers Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview
  13.1.3 Pfizer Pain Relievers Introduction
  13.1.4 Pfizer Revenue in Pain Relievers Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 GSK
  13.2.1 GSK Company Details
  13.2.2 GSK Business Overview
  13.2.3 GSK Pain Relievers Introduction
  13.2.4 GSK Revenue in Pain Relievers Business (2015-2020)
  13.2.5 GSK Recent Development
13.3 Grunenthal
  13.3.1 Grunenthal Company Details
  13.3.2 Grunenthal Business Overview
  13.3.3 Grunenthal Pain Relievers Introduction
  13.3.4 Grunenthal Revenue in Pain Relievers Business (2015-2020)
  13.3.5 Grunenthal Recent Development
13.4 Bayer
  13.4.1 Bayer Company Details
  13.4.2 Bayer Business Overview
  13.4.3 Bayer Pain Relievers Introduction
  13.4.4 Bayer Revenue in Pain Relievers Business (2015-2020)
  13.4.5 Bayer Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview
  13.5.3 Sanofi Pain Relievers Introduction
  13.5.4 Sanofi Revenue in Pain Relievers Business (2015-2020)
  13.5.5 Sanofi Recent Development
13.6 Eli Lilly
  13.6.1 Eli Lilly Company Details
  13.6.2 Eli Lilly Business Overview
  13.6.3 Eli Lilly Pain Relievers Introduction
  13.6.4 Eli Lilly Revenue in Pain Relievers Business (2015-2020)
  13.6.5 Eli Lilly Recent Development
13.7 AstraZeneca
  13.7.1 AstraZeneca Company Details
  13.7.2 AstraZeneca Business Overview
  13.7.3 AstraZeneca Pain Relievers Introduction
  13.7.4 AstraZeneca Revenue in Pain Relievers Business (2015-2020)
  13.7.5 AstraZeneca Recent Development
13.8 Endo
  13.8.1 Endo Company Details
  13.8.2 Endo Business Overview
  13.8.3 Endo Pain Relievers Introduction
  13.8.4 Endo Revenue in Pain Relievers Business (2015-2020)
  13.8.5 Endo Recent Development
13.9 Merck
  13.9.1 Merck Company Details
  13.9.2 Merck Business Overview
  13.9.3 Merck Pain Relievers Introduction
  13.9.4 Merck Revenue in Pain Relievers Business (2015-2020)
  13.9.5 Merck Recent Development
13.10 Depomed
  13.10.1 Depomed Company Details
  13.10.2 Depomed Business Overview
  13.10.3 Depomed Pain Relievers Introduction
  13.10.4 Depomed Revenue in Pain Relievers Business (2015-2020)
  13.10.5 Depomed Recent Development
13.11 Yunnan Baiyao
  10.11.1 Yunnan Baiyao Company Details
  10.11.2 Yunnan Baiyao Business Overview
  10.11.3 Yunnan Baiyao Pain Relievers Introduction
  10.11.4 Yunnan Baiyao Revenue in Pain Relievers Business (2015-2020)
  10.11.5 Yunnan Baiyao Recent Development
13.12 Teva
  10.12.1 Teva Company Details
  10.12.2 Teva Business Overview
  10.12.3 Teva Pain Relievers Introduction
  10.12.4 Teva Revenue in Pain Relievers Business (2015-2020)
  10.12.5 Teva Recent Development
13.13 J&J
  10.13.1 J&J Company Details
  10.13.2 J&J Business Overview
  10.13.3 J&J Pain Relievers Introduction
  10.13.4 J&J Revenue in Pain Relievers Business (2015-2020)
  10.13.5 J&J Recent Development
13.14 Allergan
  10.14.1 Allergan Company Details
  10.14.2 Allergan Business Overview
  10.14.3 Allergan Pain Relievers Introduction
  10.14.4 Allergan Revenue in Pain Relievers Business (2015-2020)
  10.14.5 Allergan Recent Development
13.15 Purdue
  10.15.1 Purdue Company Details
  10.15.2 Purdue Business Overview
  10.15.3 Purdue Pain Relievers Introduction
  10.15.4 Purdue Revenue in Pain Relievers Business (2015-2020)
  10.15.5 Purdue Recent Development
13.16 Reckitt Benckiser Group Plc
  10.16.1 Reckitt Benckiser Group Plc Company Details
  10.16.2 Reckitt Benckiser Group Plc Business Overview
  10.16.3 Reckitt Benckiser Group Plc Pain Relievers Introduction
  10.16.4 Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2015-2020)
  10.16.5 Reckitt Benckiser Group Plc Recent Development
13.17 Novartis AG
  10.17.1 Novartis AG Company Details
  10.17.2 Novartis AG Business Overview
  10.17.3 Novartis AG Pain Relievers Introduction
  10.17.4 Novartis AG Revenue in Pain Relievers Business (2015-2020)
  10.17.5 Novartis AG Recent Development
13.18 Topical BioMedics
  10.18.1 Topical BioMedics Company Details
  10.18.2 Topical BioMedics Business Overview
  10.18.3 Topical BioMedics Pain Relievers Introduction
  10.18.4 Topical BioMedics Revenue in Pain Relievers Business (2015-2020)
  10.18.5 Topical BioMedics Recent Development
13.19 AdvaCare Pharma
  10.19.1 AdvaCare Pharma Company Details
  10.19.2 AdvaCare Pharma Business Overview
  10.19.3 AdvaCare Pharma Pain Relievers Introduction
  10.19.4 AdvaCare Pharma Revenue in Pain Relievers Business (2015-2020)
  10.19.5 AdvaCare Pharma Recent Development
13.20 Sun Pharmaceutical
  10.20.1 Sun Pharmaceutical Company Details
  10.20.2 Sun Pharmaceutical Business Overview
  10.20.3 Sun Pharmaceutical Pain Relievers Introduction
  10.20.4 Sun Pharmaceutical Revenue in Pain Relievers Business (2015-2020)
  10.20.5 Sun Pharmaceutical Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Pain Relievers Key Market Segments
Table 2. Key Players Covered: Ranking by Pain Relievers Revenue
Table 3. Ranking of Global Top Pain Relievers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pain Relievers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 6. Key Players of Central Analgesics
Table 7. Global Pain Relievers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pain Relievers Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pain Relievers Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pain Relievers Market Share by Regions (2015-2020)
Table 11. Global Pain Relievers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pain Relievers Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pain Relievers Market Growth Strategy
Table 17. Main Points Interviewed from Key Pain Relievers Players
Table 18. Global Pain Relievers Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pain Relievers Market Share by Players (2015-2020)
Table 20. Global Top Pain Relievers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pain Relievers as of 2019)
Table 21. Global Pain Relievers by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pain Relievers Product Solution and Service
Table 24. Date of Enter into Pain Relievers Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pain Relievers Market Size Share by Type (2015-2020)
Table 28. Global Pain Relievers Revenue Market Share by Type (2021-2026)
Table 29. Global Pain Relievers Market Size Share by Application (2015-2020)
Table 30. Global Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pain Relievers Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pain Relievers Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pain Relievers Market Share (2019-2020)
Table 34. North America Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pain Relievers Market Share by Type (2015-2020)
Table 36. North America Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pain Relievers Market Share by Application (2015-2020)
Table 38. Europe Key Players Pain Relievers Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pain Relievers Market Share (2019-2020)
Table 40. Europe Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pain Relievers Market Share by Type (2015-2020)
Table 42. Europe Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pain Relievers Market Share by Application (2015-2020)
Table 44. China Key Players Pain Relievers Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pain Relievers Market Share (2019-2020)
Table 46. China Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 47. China Pain Relievers Market Share by Type (2015-2020)
Table 48. China Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 49. China Pain Relievers Market Share by Application (2015-2020)
Table 50. Japan Key Players Pain Relievers Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pain Relievers Market Share (2019-2020)
Table 52. Japan Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pain Relievers Market Share by Type (2015-2020)
Table 54. Japan Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pain Relievers Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pain Relievers Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pain Relievers Market Share (2019-2020)
Table 58. Southeast Asia Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pain Relievers Market Share by Type (2015-2020)
Table 60. Southeast Asia Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pain Relievers Market Share by Application (2015-2020)
Table 62. India Key Players Pain Relievers Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pain Relievers Market Share (2019-2020)
Table 64. India Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 65. India Pain Relievers Market Share by Type (2015-2020)
Table 66. India Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 67. India Pain Relievers Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pain Relievers Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pain Relievers Market Share (2019-2020)
Table 70. Central & South America Pain Relievers Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pain Relievers Market Share by Type (2015-2020)
Table 72. Central & South America Pain Relievers Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pain Relievers Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. GSK Company Details
Table 80. GSK Business Overview
Table 81. GSK Product
Table 82. GSK Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 83. GSK Recent Development
Table 84. Grunenthal Company Details
Table 85. Grunenthal Business Overview
Table 86. Grunenthal Product
Table 87. Grunenthal Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 88. Grunenthal Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Product
Table 92. Bayer Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 93. Bayer Recent Development
Table 94. Sanofi Company Details
Table 95. Sanofi Business Overview
Table 96. Sanofi Product
Table 97. Sanofi Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 98. Sanofi Recent Development
Table 99. Eli Lilly Company Details
Table 100. Eli Lilly Business Overview
Table 101. Eli Lilly Product
Table 102. Eli Lilly Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 103. Eli Lilly Recent Development
Table 104. AstraZeneca Company Details
Table 105. AstraZeneca Business Overview
Table 106. AstraZeneca Product
Table 107. AstraZeneca Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 108. AstraZeneca Recent Development
Table 109. Endo Business Overview
Table 110. Endo Product
Table 111. Endo Company Details
Table 112. Endo Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 113. Endo Recent Development
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Product
Table 117. Merck Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 118. Merck Recent Development
Table 119. Depomed Company Details
Table 120. Depomed Business Overview
Table 121. Depomed Product
Table 122. Depomed Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 123. Depomed Recent Development
Table 124. Yunnan Baiyao Company Details
Table 125. Yunnan Baiyao Business Overview
Table 126. Yunnan Baiyao Product
Table 127. Yunnan Baiyao Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 128. Yunnan Baiyao Recent Development
Table 129. Teva Company Details
Table 130. Teva Business Overview
Table 131. Teva Product
Table 132. Teva Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 133. Teva Recent Development
Table 134. J&J Company Details
Table 135. J&J Business Overview
Table 136. J&J Product
Table 137. J&J Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 138. J&J Recent Development
Table 139. Allergan Company Details
Table 140. Allergan Business Overview
Table 141. Allergan Product
Table 142. Allergan Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 143. Allergan Recent Development
Table 144. Purdue Company Details
Table 145. Purdue Business Overview
Table 146. Purdue Product
Table 147. Purdue Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 148. Purdue Recent Development
Table 149. Reckitt Benckiser Group Plc Company Details
Table 150. Reckitt Benckiser Group Plc Business Overview
Table 151. Reckitt Benckiser Group Plc Product
Table 152. Reckitt Benckiser Group Plc Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 153. Reckitt Benckiser Group Plc Recent Development
Table 154. Novartis AG Company Details
Table 155. Novartis AG Business Overview
Table 156. Novartis AG Product
Table 157. Novartis AG Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 158. Novartis AG Recent Development
Table 159. Topical BioMedics Company Details
Table 160. Topical BioMedics Business Overview
Table 161. Topical BioMedics Product
Table 162. Topical BioMedics Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 163. Topical BioMedics Recent Development
Table 164. AdvaCare Pharma Company Details
Table 165. AdvaCare Pharma Business Overview
Table 166. AdvaCare Pharma Product
Table 167. AdvaCare Pharma Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 168. AdvaCare Pharma Recent Development
Table 169. Sun Pharmaceutical Company Details
Table 170. Sun Pharmaceutical Business Overview
Table 171. Sun Pharmaceutical Product
Table 172. Sun Pharmaceutical Revenue in Pain Relievers Business (2015-2020) (Million US$)
Table 173. Sun Pharmaceutical Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Pain Relievers Market Share by Type: 2020 VS 2026
Figure 2. Nonsteroidal Anti-inflammatory Drugs Features
Figure 3. Central Analgesics Features
Figure 4. Global Pain Relievers Market Share by Application: 2020 VS 2026
Figure 5. Headache Case Studies
Figure 6. Toothache Case Studies
Figure 7. Arthralgia Case Studies
Figure 8. Menstrual Pain Case Studies
Figure 9. Other Case Studies
Figure 10. Pain Relievers Report Years Considered
Figure 11. Global Pain Relievers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pain Relievers Market Share by Regions: 2020 VS 2026
Figure 13. Global Pain Relievers Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pain Relievers Market Share by Players in 2019
Figure 16. Global Top Pain Relievers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pain Relievers as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pain Relievers Revenue in 2019
Figure 18. North America Pain Relievers Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pain Relievers Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pain Relievers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pain Relievers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pain Relievers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pain Relievers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pain Relievers Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed


More Publications